|1.||Sonobe, Takashi: 1 article (07/2015)|
|2.||Haouzi, Philippe: 1 article (07/2015)|
|3.||Prindeze, Nicholas J: 1 article (01/2015)|
|4.||Moffatt, Lauren T: 1 article (01/2015)|
|5.||Foveau, Bénédicte: 1 article (01/2015)|
|6.||Kaushal, Vikas: 1 article (01/2015)|
|7.||LeBlanc, Andrea C: 1 article (01/2015)|
|8.||Paul, Dereck W: 1 article (01/2015)|
|9.||Ghassemi, Pejhman: 1 article (01/2015)|
|10.||Ramella-Roman, Jessica C: 1 article (01/2015)|
|1.||Melanoma (Melanoma, Malignant)
07/01/2005 - "Dako's EnVision ultrarapid staining protocol and azure B counterstain represent a dramatic improvement and should be considered the easily obtainable histologic standard when excising cutaneous melanoma."
12/01/1999 - "We conclude that the use of azure B counterstaining is superior to permanganate bleaching in the histologic evaluation of heavily pigmented cutaneous malignant melanomas."
12/01/1999 - "To our knowledge, studies comparing melanin bleaching with azure B counterstaining in the immunohistochemical evaluation of malignant melanomas have not been performed. "
|3.||Alzheimer Disease (Alzheimer's Disease)
02/01/2014 - "Although the AChE and BuChE inhibitory activities of azure B are twofold and fivefold, respectively, less potent than those recorded for MB [IC50(AChE)=0.214μM; IC50(BuChE)=0.389μM] under identical conditions, azure B may be a contributor to MB's in vivo activation of the cholinergic system and beneficial effects in Alzheimer's disease. "
01/01/1988 - "A new double-staining procedure, in which the techniques of immunocytochemistry of glial fibrillary acidic protein (GFAP) and quantitative microdensitometry of azure B-RNA were combined, was used to study nucleic acid alterations in fibrous astrocytes in Alzheimer's disease (AD). "
12/01/1995 - "Scanning and integrating microdensitometry of azure B- and Coomassie brilliant blue G-stained tissue sections was used to measure the levels of RNA and protein, respectively, in pyramidal neurons of the insular cortex (INS) and midfrontal gyrus (MFG) in patients with Alzheimer's disease (AD) and age-matched, nondemented control subjects. "
02/01/1987 - "Scanning-integrating microdensitometry of azure B-RNA- and Feulgen-Schiff-stained tissue sections was used to measure neostriatal neuronal RNA levels and susceptibility of neuronal and oligodendrocyte chromatin to acid hydrolysis in Alzheimer's disease (AD) patients and controls. "
12/01/1991 - "Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms."
11/01/1991 - "The biological stains, methylene blue and its metabolite azure B, were evaluated as anti-tumor and anti-inflammatory agents. "
01/01/1993 - "were treated with peptidoglycan monomer, azure B and indomethacin for one month, either from day 0 or 75 after methylcholanthrene injection to assess their effects on tumor incidence (on days 150 and 300), time of tumor appearance, time of death, and duration and dynamics of tumor growth. "
|5.||Ganglion Cysts (Ganglion)
|2.||permanganic acid (permanganate)
|3.||RNA (Ribonucleic Acid)
|4.||Glial Fibrillary Acidic Protein
|5.||Methylene Blue (Methylthioninium Chloride)